News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike
News Novavax secures full EU approval for COVID-19 vaccine Nuvaxo... In the first of a double dose of wins for US biotech Novavax, the company has been granted full marketing authorisation (MA) by the
News Janssen's quarterly schizophrenia drug approved in EU Company hopes new formulation will improve patient outcomes.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
